Amvuttra
Amvuttra
AMVUTTRA is a transthyretin-directed small interfering RNA indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
It has shown significant improvement in nerve function and quality of life including walking, nutritional health, and ability to perform daily activities.
Administration Information
AMVUTTRA is 25 mg administered by subcutaneous injection once every 3 months.
Potential Side Effects
Two serious adverse reactions of atrioventricular (AV) heart block (1.6%) occurred in patients treated with AMVUTTRA, including one case of complete AV block.
Injection site reactions were reported in 5 (4%) patients treated with AMVUTTRA. Reported symptoms included bruising, erythema, pain, pruritus, and warmth. Injection site reactions were mild and transient.
Helpful Resources
How Amvuttra may help
Possible Side Effects
Patient Resources
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Patient Consent Form
HIPAA Privacy Authorization Form
Notice of Privacy Practices
Patient Rights and Responsibilities
Appointment Lateness and Cancelation
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP
Brandon See Location
Clearwater See Location
Fort Myers See Location
Ocala Coming Soon See Location
Orlando See Location
Sarasota See Location
St. Petersburg Coming Soon See Location
Tampa See Location
The Villages Lake Sumter See Location
The Villages Spanish Springs See Location